E
Eugenia Nikolsky
Researcher at Technion – Israel Institute of Technology
Publications - 141
Citations - 17047
Eugenia Nikolsky is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 50, co-authored 141 publications receiving 15364 citations. Previous affiliations of Eugenia Nikolsky include Lenox Hill Hospital & Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
Spontaneous healing of long, catheter-induced right coronary artery dissection
TL;DR: In this paper, the authors describe the spontaneous healing of long, catheter-induced right coronary artery dissection from a single-stage dissection using a single catheter, and show that it is possible to do so without surgery.
Journal ArticleDOI
Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease
Noam Fink,Eugenia Nikolsky,Abid Assali,Oz M. Shapira,Yigal Kassif,Yaron D. Barac,Ariel Finkelstein,Amnon Eitan,Haim D. Danenberg,Doron Zahger,Gideon Sahar,Shaul Atar,Ehud Raanani,Gil Bolotin,Ilan Goldenberg,Amit Segev +15 more
TL;DR: Good agreement with current guidelines regarding revascularization strategies in real-world patients with multivessel CAD is found and the time-dependent association between revascularized strategy and long-term survival should be incorporated in the risk assessment of this population.
Journal ArticleDOI
Response to Letter Regarding Article, “Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial”
Gregg W. Stone,Roxana Mehran,Eugenia Nikolsky,Helen Parise,Martin Fahy,Alexandra J. Lansky,Jeffrey W. Moses,Stuart J. Pocock,Tim Clayton,Michel E. Bertrand,A. Michael Lincoff,E. Magnus Ohman,Harvey D. White +12 more
TL;DR: Either a larger sample size, higher baseline mortality rate, or greater proportion of deaths due to the postprocedural complications of ischemia and bleeding would be required for the relative benefits of bivalirudin compared with heparin plus glycoprotein IIb/IIIa inhibitors to result in a statistically significant reduction in mortality.
Journal ArticleDOI
Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.
Warren J. Cantor,Warren J. Cantor,Sergio B. Baptista,Vankeepuram S. Srinivas,Camille A. Pearte,Venu Menon,Zygmunt Sadowski,John R. Ross,Peter Mečiar,Eugenia Nikolsky,Sandra A. Forman,Gervasio A. Lamas,Judith S. Hochman +12 more
TL;DR: In the Occluded Artery Trial, patients who underwent stress testing had better outcomes than patients who did not, likely related to differences in baseline characteristics.
Journal ArticleDOI
Cerebrovascular Events After a Primary Percutaneous Coronary Intervention Strategy for Acute ST-Segment– Elevation Myocardial Infarction Analysis From the HORIZONS-AMI Trial
Eugenia Nikolsky,Roxana Mehran,George Dangas,Ke Xu,Rupa Parvataneni,Bernhard Witzenbichler,Giulio Guagliumi,Ran Kornowski,Philippe Généreux,Sorin J. Brener,Gregg W. Stone +10 more
TL;DR: In HORIZONS-AMI, cerebrovascular events within 3 years after ST-segment–elevation myocardial infarction in patients undergoing a primary percutaneous coronary intervention management strategy occurred in 2.0% of patients and were most frequent after coronary artery bypass grafting.